Last Updated: May 2026

Psychedelic therapy in California is a complicated picture in 2026. Ketamine is the one legally accessible option through licensed medical providers, while psilocybin remains a Schedule I substance under both state and federal law, despite local decriminalization in several cities. If you are exploring psychedelic therapy in California right now, the pathway to safe, supported access requires careful navigation.

California has one of the most active psychedelic policy conversations in the country, which makes it all the more confusing for people trying to understand what is actually available to them. Headlines about decriminalization in Oakland or San Francisco can make it seem like the state is on the verge of something major. The reality, as of 2026, is more complicated and more legally constrained than those headlines suggest.

This guide lays out what is currently legal in California, what is not, where the legislation stands, and how to find qualified support if you are genuinely ready to explore this work.

The One Option That Is Fully Legal Right Now: Ketamine

If you are looking for a legally accessible psychedelic-adjacent therapy in California today, ketamine is the clearest option. As a Schedule III controlled substance, ketamine can be prescribed by licensed physicians for off-label mental health use, including treatment-resistant depression, PTSD, and anxiety. California is home to more than 200 ketamine providers, making it one of the most accessible states in the country for this treatment.

Esketamine, sold under the brand name Spravato, is the only FDA-approved psychedelic-derived treatment currently available for treatment-resistant depression. It can be administered in clinical settings and, in some cases, is covered by Medi-Cal when specific clinical criteria are met. Standard IV ketamine infusions are a legal off-label treatment administered at physician-owned clinics throughout the state.

California strengthened its Corporate Practice of Medicine rules in 2025 through SB 351, which further limits private equity from controlling clinical decisions at ketamine and other specialty practices. This is worth knowing if you are vetting providers: all California ketamine clinics are legally required to be physician-owned and clinically directed.

Ketamine is not the same as psilocybin. It has a different mechanism, a shorter duration, and a distinct evidence base. But for many people, it is the most viable legal entry point into professionally supported psychedelic-assisted care, and it should not be dismissed as a lesser option. It is real clinical treatment with a real track record.

Psilocybin in California: What the Law Actually Says

Psilocybin remains illegal under California state law and federal law in 2026. That sentence is worth sitting with, because a lot of media coverage around SB-58 and local decriminalization measures creates the impression that something substantive has changed. It has not, at the state level.

Here is the relevant history. SB-58, introduced by State Senator Scott Wiener, would have decriminalized personal possession of psilocybin, psilocin, DMT, and mescaline for adults 21 and older starting January 1, 2025. The bill passed both chambers of the California legislature. Governor Gavin Newsom vetoed it in October 2023, citing the need for a more structured framework with dosing guidelines, therapeutic protocols, and safeguards against exploitation before any broad decriminalization could move forward.

Subsequent legislative efforts have not closed the gap. SB 1012 in 2024, which would have created a licensed facilitated-use framework, failed in committee. SB 751 in 2025, a more limited pilot program focused on veterans, also did not pass. As of early 2026, California has not enacted statewide decriminalization or any licensed therapeutic access model for psilocybin.

What California did pass in 2025 is AB 1103, which modernizes and streamlines the state’s research approval process for Schedule I and II substances. This positions California as a significant hub for psychedelic research, particularly at institutions like UCSF and UCLA, but it does not create any public access pathway. Participation in an approved clinical trial remains the only lawful route to psilocybin use in California outside of a decriminalized city.

City-Level Decriminalization: What It Does and Does Not Mean

Several California cities have adopted measures that make enforcement of psilocybin possession laws the lowest priority for local police. Oakland, Santa Cruz, San Francisco, Berkeley, Arcata, and Eureka all have some form of local deprioritization in place. These measures matter for practical reasons, but they are frequently misunderstood.

Local decriminalization does not change state law. It does not create a legal right to possess, cultivate, or use psilocybin. State and federal agencies can still enforce existing laws regardless of city-level policies. Moving psilocybin across city limits, even from a decriminalized city to a neighboring one, reintroduces full legal exposure. And critically, no California city has created a legal framework for facilitated therapeutic use. Sitting with a guide in Oakland is not protected activity under any current ordinance.

This matters because the line between personal use and facilitated therapeutic use is not just a legal one. It is a safety one. Psychedelic therapy California seekers are genuinely looking for is not simply access to a substance. It is access to a structured, professionally supported experience with proper preparation and integration. That is not what decriminalization provides.

Retreat Options and Cross-State Access

Some California residents choose to access psilocybin therapy in Oregon or Colorado, where regulated therapeutic frameworks are operational. Oregon’s licensed psilocybin services program allows facilitated sessions at licensed service centers. Colorado’s healing center model, which launched licensed access in 2025, offers a similar pathway. These are legal options for adults who are willing to travel and who engage with properly licensed facilitators within those states.

Retreat options operating within California using psilocybin are not legally sanctioned. Anyone offering facilitated psilocybin sessions in California outside of an approved research trial is operating outside the law, regardless of how the service is marketed. This is a real safety consideration, not just a legal one. The quality of care, the screening process, and the integration support at unlicensed retreats vary widely, and there is no regulatory oversight to ensure minimum standards.

For a broader look at how California fits into the national landscape, see our overview post: Is Psychedelic Therapy Legal in the United States?

What to Look for in a Psychedelic Guide in California

Even within legal constraints, the quality of preparation and integration support varies enormously. If you are exploring psychedelic therapy in California, whether through ketamine, through a clinical trial, or with a plan to access treatment in Oregon or Colorado, working with a qualified guide who understands your full clinical picture makes a significant difference in outcomes.

A qualified psychedelic guide in California should have verifiable training in psychedelic-assisted care, not just familiarity with the substances. They should conduct thorough screening before any session, including mental health history, contraindicated medications, and personal intentions. They should offer structured preparation sessions before the experience and dedicated integration sessions afterward. And they should be transparent about the legal context of whatever they are offering.

Red flags include providers who skip intake screening, who promise specific outcomes, or who offer psilocybin sessions without being clear about the legal status of what they are doing. The psychedelic guide California seekers need is one who can hold complexity: clinical knowledge, legal awareness, and genuine care for safety over novelty.

What to Do Right Now

If you are a California resident curious about psychedelic therapy but unsure where to start, the most useful first step is a structured conversation about your specific situation. Not every person is a candidate for every modality. Ketamine may be the right fit now. A clinical trial may be appropriate. Travel to a regulated state for psilocybin services may be something you want to plan. Integration work with an experienced guide may be what is needed before anything else.

JourneyŌM works as a concierge service, which means we help you understand your options clearly before you commit to any particular path. We match seekers with vetted professional guides who have the clinical grounding and the legal context to give you an honest picture. We support preparation, the experience itself, and the integration that follows.

California’s legal landscape for psychedelic therapy is moving, but it is not there yet for psilocybin. In the meantime, there are real, supported, lawful options worth knowing about. Start with a conversation.

Ready to explore your options?

  • Is This Right for Me? — Self-Evaluation — A confidential self-assessment to help you understand your readiness and whether a guided experience is a fit. The right starting point if you’re still exploring.
  • Start with a Conversation — A complimentary 15-minute call with the JourneyŌM team. No pressure, just clarity on where you are and what’s possible.
  • Concierge Consultation — A full intake session for seekers ready to move forward. We listen, assess fit, and only proceed to matching if it’s right for both sides. See pricing

Sources